Cigna Corporation Financial Statements (CI) |
||||||||||
Cigna Corporationsmart-lab.ru | % | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
---|---|---|---|---|---|---|---|---|---|---|
Report date | 02.11.2023 | 31.12.2023 | 29.02.2024 | 02.05.2024 | 01.08.2024 | 01.08.2024 | ||||
Currency | USD | USD | USD | USD | USD | USD | ||||
Financial report URL | ||||||||||
Revenue, bln rub | ? | 49 048 | 51 114 | 51 080 | 55 419 | 60 475 | 218 088 | |||
Operating Income, bln rub | 2 240 | 1 029 | 1 029 | 2 256 | 2 412 | 6 726 | ||||
EBITDA, bln rub | ? | 2 240 | 1 029 | 1 029 | -2 242 | 2 412 | 2 228 | |||
Net profit, bln rub | ? | 41.0 | 1 029 | 1 029 | -277.0 | 1 548 | 3 329 | |||
OCF, bln rub | ? | 2 826 | 0.000 | 1 467 | 4 840 | 265.0 | 6 572 | |||
CAPEX, bln rub | ? | 403.0 | 0.000 | 365.0 | 300.0 | 370.0 | 1 035 | |||
FCF, bln rub | ? | 2 423 | 0.000 | 1 102 | 4 540 | -105.0 | 5 537 | |||
Dividend payout, bln rub | 362.0 | 0.000 | 358.0 | 401.0 | 392.0 | 1 151 | ||||
Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
Dividend payout ratio, % | 882.9% | 0.00% | 34.8% | 0.00% | 25.3% | 34.6% | ||||
OPEX, bln rub | 3 788 | 50 085 | 39 497 | 45 522 | 48 533 | 183 637 | ||||
Cost of production, bln rub | 8 927 | 0.000 | 9 280 | 9 440 | 9 515 | 28 235 | ||||
R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
Interest expenses, bln rub | 365.0 | 0.000 | 360.0 | 322.0 | 375.0 | 1 057 | ||||
Assets, bln rub | 149 645 | 0.000 | 147 926 | 148 447 | 150 851 | 150 851 | ||||
Net Assets, bln rub | ? | 45 691 | 46 223 | 46 223 | 41 181 | 41 332 | 41 332 | |||
Debt, bln rub | 31 140 | 0.000 | 31 480 | 32 768 | 31 892 | 31 892 | ||||
Cash, bln rub | 9 543 | 0.000 | 8 747 | 9 547 | 7 856 | 7 856 | ||||
Net debt, bln rub | 21 597 | 0.00 | 22 733 | 23 221 | 24 036 | 24 036 | ||||
Ordinary share price, rub | 286.1 | 299.5 | 299.5 | 363.2 | 330.6 | 318.9 | ||||
Number of ordinary shares, mln | 294.1 | 294.6 | 292.5 | 286.5 | 281.1 | 281.1 | ||||
Market cap, bln rub | 84 121 | 88 207 | 87 590 | 104 041 | 92 934 | 89 653 | ||||
EV, bln rub | ? | 105 718 | 88 207 | 110 323 | 127 262 | 116 970 | 113 689 | |||
Book value, bln rub | -31 443 | 46 223 | -28 899 | -33 568 | -33 102 | -33 102 | ||||
EPS, rub | ? | 0.14 | 3.49 | 3.52 | -0.97 | 5.51 | 11.8 | |||
FCF/share, rub | 8.24 | 0.00 | 3.77 | 15.8 | -0.37 | 19.7 | ||||
BV/share, rub | -106.9 | 156.9 | -98.8 | -117.2 | -117.7 | -117.7 | ||||
EBITDA margin, % | ? | 4.57% | 2.01% | 2.01% | -4.05% | 3.99% | 1.02% | |||
Net margin, % | ? | 0.08% | 2.01% | 2.01% | -0.50% | 2.56% | 1.53% | |||
FCF yield, % | ? | 12.9% | 10.4% | 11.7% | 9.77% | 8.57% | 6.18% | |||
ROE, % | ? | 8.62% | 8.21% | 8.21% | 5.47% | 5.66% | 8.05% | |||
ROA, % | ? | 2.63% | 2.57% | 1.52% | 1.55% | 2.21% | ||||
P/E | ? | 21.4 | 23.2 | 23.1 | 46.2 | 39.7 | 26.9 | |||
P/FCF | 7.72 | 9.65 | 8.55 | 10.2 | 11.7 | 16.2 | ||||
P/S | ? | 0.44 | 0.45 | 0.45 | 0.51 | 0.43 | 0.41 | |||
P/BV | ? | -2.68 | 1.91 | -3.03 | -3.10 | -2.81 | -2.71 | |||
EV/EBITDA | ? | 12.0 | 11.8 | 14.7 | 39.2 | 34.0 | 51.0 | |||
Debt/EBITDA | 2.44 | 0.00 | 3.03 | 7.15 | 6.99 | 10.8 | ||||
R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
CAPEX/Revenue, % | 0.82% | 0.00% | 0.71% | 0.54% | 0.61% | 0.47% | ||||
Cigna Corporation shareholders |